key: cord-0983064-1zuc6ejo authors: Morau, Estelle; Bouvet, Lionel; Keita, Hawa; Vial, Florence; Bonnet, Marie Pierre; Bonnin, Martine; Gouez, Agnès Le; Chassard, Dominique; Mercier, Frédéric J; Benhamou, Dan title: Anaesthesia and intensive care in obstetrics during the COVID-19 pandemic date: 2020-05-13 journal: Anaesth Crit Care Pain Med DOI: 10.1016/j.accpm.2020.05.006 sha: bb3c6db0701a702d081227a67e55ce4c6e20d239 doc_id: 983064 cord_uid: 1zuc6ejo nan Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is extremely contagious 1 , with droplet transmission from coughing, sneezing or even normal breathing and speech or by close or direct contact. Challenges in containing the transmission relate to the incubation period, with asymptomatic carriers being able to transmit the infection 2 . Therefore, community transmission poses a serious threat, along with in-hospital exposure for both healthcare providers (HCP) and patients, resulting in the possible collapse of the healthcare system 3 . Pregnancy is a unique condition; optimal antenatal care includes serial obstetric consultations and pre-anaesthesia assessment to reduce maternal and neonatal morbidity 4 . Nosocomial transmission of COVID-19 infection represents a serious threat to health care systems: In a single-centre case series of 138 hospitalised patients with confirmed COVID-19 pneumonia in Wuhan, China, presumed hospital-related transmission of COVID-19 was suspected in 41% of patients 5 . The clinical environment of LDU (e.g. fast pace, emergencies, high volume) significantly increases the risk for work-related transmission for the various HCP working in LDU (obstetricians, anaesthetists, midwifes, nurse anaesthetists, neonatologists…). Hence, the usual approaches to maternal care need to be modified in order to minimise contamination and transmission of COVID-19 among women, their families, the HCP, while ensuring high standards of maternal care 6 . In view of the high risk of transmission in the LDU, remote consultations and at home followup have been encouraged and rapidly developed. French laws were updated to allow an extensive use of teleconsultations 7, 8 . Home visits may be provided by independent midwives networking with the maternity services. Maintaining in person consultations for high-risk pregnant women (e.g. with significant comorbidities or pregnancy-associated complications), can be optimised by scheduling multiple consultations at the same time and promoting a cohesive multidisciplinary approach. Since the beginning of the pandemic, remote pre-anaesthesia consultations have been offered 9 and a dedicated website providing information for expectant mothers has been developed 10 . For women with planned admissions for induction of labour or caesarean delivery, it is recommended to have a phone screening (the interview should also involve the birthing partner) the day before admission. Based on the World Health Organisation (WHO) recommendation 11 and national policies 12 a pre-admission triage system to screen pregnant women for COVID-19 symptoms (fever, cough, diarrhoea, possible exposure) is recommended in all LDU; this can be managed by nurses at the entrance of LDU. Women deemed suspicious, also termed person under investigation, are directed to a dedicated area, in anticipation of "segregation" and a specific care pathway to avoid contamination of hospital areas and HCP exposure. Concomitantly, standard precautions for all women admitted to LDU and their partners should include hand and respiratory hygiene measures: use of alcohol-based hand scrub and face mask. Given the high prevalence of asymptomatic carriers and risk of transmission, the goal should be having every patient wear a surgical mask (limited by adequate supplies) 13 . Indeed in a recent study, after implementation of universal testing for all women admitted for delivery in a large academic centre in New York City, the incidence of COVID-19 infection Assessment of the severity of COVID-19 symptoms should be done by the senior team member of the LDU to avoid unnecessary exposure. Severe dyspnoea, respiratory distress, tachypnoea (> 30 breaths/min), or hypoxia (SpO2 < critical to severe forms of the disease (14%), which is consistent with the Chinese publications related to pregnant women 16, 17, 18 . The proportion of severe forms among pregnant women thus seems comparable with the general population. Young women can compensate for deterioration in respiratory function and are able to maintain normal oxygen saturations before they then suddenly decompensate. A rise in the respiratory rate may indicate deterioration in respiratory function. Early multidisciplinary discussion should be early organised to determine the adequate location and level of care for both mother and foetal-neonatal management. Escalation in therapy may be offered with the same cautiousness and supervision than in the non-pregnant patients (high-flow nasal oxygen or non-invasive ventilation…) to reduce the need for mechanical ventilation 19 . In the most severe situations of Acute Respiratory Distress Syndrome (ARDS) from other acute conditions 20 , Extracorporeal Life Support has already been used for pre and post partum patients for other acute conditions 20 with greater than 50% of survival rate 21 . Thus, Extracorporeal Life Support could be also an option for the management of the most severe cases of COVID-19 ARDS in pregnant or postpartum women as well as in the general population. When a pregnant woman with COVID-19 infection is > 34 weeks of gestation, timing of delivery is quite easy to handle. Indeed, in the severe form of the disease at least, birth should occur rapidly, in order to facilitate mother's care. The difficulty in decision-making arises when termination of pregnancy can lead to extreme premature birth. Decision for delivery cannot simply follow guidelines: it has to be discussed on a case-by-case basis, within a multidisciplinary team, weighting benefits and risks on an individual basis. This team should involve obstetricians, obstetrics anaesthetists, intensivists, neonatologists, the patient and her partner when possible. This decision should be re-evaluated regularly, according to the clinical evolution of the mother and to the gestational age. Indication of foetal extraction must not occur too soon (otherwise producing extreme prematurity whereas there is a chance that maternal condition will remain stable), nor too late (otherwise transport to the theatre and surgery can decompensate a very instable maternal condition). In our opinion, intubation itself and low dose catecholamine is not definitely an indication of foetal extraction by itself, but when it occurs, it should lead to close and continuous communication between all multidisciplinary team members in order to provide delivery in a timely manner if the situation worsen. There is no evidence that regional analgesia or anaesthesia is contraindicated in the presence of coronavirus. The management of suspected or confirmed COVID-19 cases should include complete blood count, as some abnormalities have been observed : severe thrombocytopenia (< 100,000 x10 6 /L) has been early described in both pregnant and nonpregnant patients 22 . Recently prolonged APTT and PT have both been described in a few cases in the general population with poor details of bleeding risk 23 . The COVID-19 outbreak does not appear to have changed the rate of epidural labour analgesia 24 . Early epidural analgesia may be indicated to reduce respiratory exhaustion in mild to severe symptomatic women and is recommended to decrease the need for general anaesthesia in case of emergent delivery. Emergency caesarean delivery due to intrauterine foetal distress was a frequent mode of delivery in the Chinese published reports 25 . Nonreassuring foetal heart rate may be consecutive to maternal fever or hypoxaemia or due to other obstetrical causes. Performing an emergency caesarean delivery in a COVID-19 patient, poses logistical safety constraints due to the time needed to don personal It is also strongly recommended that the pregnant woman wears a medical mask during epidural placement. In the first publications from China, caesarean delivery was by far the most common mode of delivery for COVID-19 pregnant women 16, 17, 18, 25, 26, 27 .It seems that urgent delivery was decided as soon as the patient required nasal oxygen supplementation even at low-flow rate. Contrastingly, some suggest that whenever possible, vaginal delivery via induction of labour should be favoured to avoid unnecessary surgical complications in an already sick patient 28 . China has already one of the highest caesarean delivery rates in the world, around 40% [29] . This trend may be further pronounced in the context of COVID-19. A recent report from Caesarean delivery may protect the foetus from viral transfer during vaginal delivery. However, no transfer of the virus from the mother to the foetus during birth was found in 13 neonates delivered vaginally 15, 17 . Moreover, vaginal fluid from a series of ten severely ill nonpregnant COVID-19 patients was tested negative for SARS-CoV-2 30 . Neuraxial anaesthesia appears to be the safer option for caesarean delivery irrespective of the COVID-19 status of the patient. Spinal or epidural anaesthesia does not appear to be associated with haemodynamic instability or respiratory decompensation (on the contrary) in pregnant women with COVID-19 infection. However, in one Chinese series, the authors reported "exaggerated decreases" in blood pressure not responding to their usual vasopressor therapy 25 (although detailed information is lacking in this report 31 ). Regional anaesthesia for caesarean delivery in COVID-19 patients, especially in case of emergency procedure is also at risk of healthcare contamination. A recent study suggested that the highest level of protective equipment appears to reduce the risk of transmission to anaesthetists who are exposed to mildly symptomatic surgical patients under spinal anaesthesia 32 . Although it should be avoided whenever possible, general anaesthesia may become indicated with deterioration of maternal respiratory function, or for or during emergency caesarean delivery. This time period represents the highest risk of exposure involving direct contact with respiratory droplets during airway management, primarily during tracheal intubation and extubation. Enhanced PPE is required for the procedure with FFP2 mask, face Page 8 of 15 J o u r n a l P r e -p r o o f shield, gown, and gloves (preferably long gloves). It is important to minimise the number of HCP in the ward, and the procedure must be performed by the most experienced staff. A highly hydrophobic filter is placed between the facemask and the breathing circuit or between facemask and bag. Another filter should be placed on the expiratory line. The anaesthetist should ensure that a closed suction system is readily available before intubation, and should consider videolaryngoscopy rather than direct laryngoscopy to minimise close exposure between staff and patient respiratory tract. After a tight seal preoxygenation with oxygen 100% to avoid aerosol generation of viral respiratory droplets, rapid sequence induction is done as per usual practice. Because cough at intubation is a major cause of viral dissemination, it is important to give a full dose of neuromuscular block and to respect onset time before laryngoscopy. Extubation also exposes staff to a significant risk of contamination. At this time, the number of HCP should be minimal, and FFP2 mask and PPE should be worn by healthcare providers. If it is decided to proceed with extubation at the end of the case, this should be done in the operating theatre while keeping PPE on until after extubation. If manual ventilation is required, only small tidal volumes should be applied. Precipitous transfers of COVID-19 patients between labour wards, operating theatres and recovery wards should be avoided whenever possible to avoid nosocomial spread. Institutional processes should be implemented in each centre. Postpartum monitoring should include thorough evaluation of COVID-19-associated complications (tachycardia, hypoxaemia, acidemia, etc.) using Modified Early Warning Score (MEWS) 33 . Since pregnancy is associated with a hypercoagulable state and with emerging evidence suggesting that patients admitted to the ICU for severe COVID-19 infection have increased Early reports have suggested that the use of NSAIDs for management of COVID-19 symptoms may worsen COVID-19 infection 34 . Caution leads to prefer other pain treatments. In case of persistent pain, occasional use is possible 35, 36 . Given the potential risks of systemic steroids in the setting of COVID-19 disease, dexamethasone for prevention of vomiting, which is not particularly effective anyway, should be avoided. Nitrous oxide, while requiring removal of the facemask, is not classified as an aerosol generating procedure, but should be used with caution with a single-patient microbiological filter 37 . Epidural analgesia should certainly be preferred in absence of thrombocytopenia. IV Opioid: parenterally administered opioids may induced respiratory and oxygen desaturation, which may subsequently lead to the need of emergent airway instrumentation and its risk of aerosolisation. Consequently, specific attention should be paid on the respiratory status of parturients receiving IV opioids for labour analgesia. Although this has been a topic of heated debates in the early period of the outbreak, most maternity units and scientific bodies now suggest that the support person be allowed during childbirth, provided that he (she) has no symptoms of COVID-19 disease, wears a surgical mask and complies with hand washing procedures. No visitor is allowed once the woman is discharged from the delivery ward nor during the stay at hospital, excepted in some cases defined by the medical team, with the same airborne and contact precautionary measures 38 . Communication in full PPE can be challenging (particularly with N95 respirators, which impair the ability to hear each other, particularly in loud environments). Preparing the teams, assigning roles and setting out the management plan improves safety and team effectiveness. Briefing and debriefing are key practices to keep the team involved and secure 39 . In situ simulation and drills are recommended to test institutional policies and practices and help their deployment. As always, it should involve a multidisciplinary team of anaesthetists, obstetricians, midwives, nurses, neonatologists, intensivists and hygienists. Additional ways to prepare and support teams, is the drafting and wide diffusion of summary sheets including cognitive aids, in the form of a checklist. In March 2020, the CARO (Club Anesthésie Réanimation en Obstétrique) designed an infographic for obstetric care of patients with suspected or confirmed COVID-19 infection. (Appendix 1) This infographic outlines the context (suspected signs; severe symptoms), proposes patient's preparation, makes recommendations based on mode of delivery (pathway; dedicated ward and team; decision regarding whether or not an accompanying person is present; necessity of PPE, other equipment; anaesthetic techniques; advised or contraindicated agents…). CARO recommends easy access to this visual aid; it should ideally be broadly displayed in maternity unit (emergency department, delivery wards, operating theatre…) The COVID-19 outbreak has profoundly challenged medical systems and clinicians' practices especially in the field where activity must go on, like in the maternity unit. In the absence of evidence-based guidelines, practical approaches involving close communication with the obstetricians have rapidly emerged to guide clinicians in these challenging times. Covid-19 -Navigating the Uncharted Transmission of 2019-NCoV Infection from an Asymptomatic Contact in Germany Practical Considerations in the Anaesthetic Management of Patients during a COVID-19 Epidemic Epidemiology of maternal mortality in France Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Maternal Health Care Management during the Outbreak of Coronavirus Disease 2019 (COVID-19) Rapid responses in the framework of COVID-19 -Continuity of pregnant women follow up HAS. Rapid responses in the framework of COVID-19 Remote Proposals Concerning the Management of a Woman Suspected/Attained with Covid 19 (SARS-COV2) for Childbirth Analgesia Clinical management of severe acute respiratory infection when COVID-19 is suspected Ministry of Health. Covid-19 Preparing Practical Recommendations for Critical Care and Anesthesiology Teams Caring for Novel Coronavirus (2019-NCoV) Patients Universal Screening for SARS-CoV-2 in Women Admitted for Delivery COVID-19 Infection among Asymptomatic and Symptomatic Pregnant Women: Two Weeks of Confirmed Presentations to an Affiliated Pair of New York City Hospitals Clinical Manifestations and Outcome of SARS-CoV-2 Infection during Pregnancy Clinical Analysis of 10 Neonates Born to Mothers with 2019-NCoV Pneumonia Clinical Features and Obstetric and Neonatal Outcomes of Pregnant Patients with COVID-19 in Wuhan, China: A Retrospective, Single-Centre, Descriptive Study Use of High Flow Oxygenation (HFO) and NIV in COVID+ Patients. Société Française d'Anesthésie et de Réanimation Maternal Salvage With Extracorporeal Life Support: Lessons Learned in a Single Center Extracorporeal Membrane Oxygenation in Pregnancy: An Analysis of the Extracorporeal Life Support Organization Registry Thrombocytopenia Is Associated with Severe Coronavirus Disease 2019 (COVID-19) Infections: A Meta-Analysis Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 Neuraxial Procedures in COVID-19 Positive Parturients: A Review of Current Reports Safety and Efficacy of Different Anesthetic Regimens for Parturients with COVID-19 Undergoing Cesarean Delivery: A Case Series of 17 Patients Clinical Analysis of Pregnant Women with 2019 Novel Coronavirus Pneumonia Clinical Characteristics and Intrauterine Vertical Transmission Potential of COVID-19 Infection in Nine Pregnant Women: A Retrospective Review of Medical Records -NCoV Epidemic: What about Pregnancies? Trends in Cesarean Delivery Rates in China SARS-CoV-2 Is Not Detectable in the Vaginal Fluid of Women with Severe COVID-19 Infection Spinal Anesthesia for Cesarean Delivery in Women with Covid-19 Infection (Letter to the Editor) Spinal Anaesthesia for Patients with Coronavirus Disease 2019 and Possible Transmission Rates in Anaesthetists: Retrospective, Single-Centre, Observational Cohort Study Abir, G. Maternal Early Warning Scores Covid-19: Ibuprofen Should Not Be Used for Managing Symptoms, Say Doctors and Scientists SFAR / SFETD Recommandations on NSAID Use Mixture of Oxygen and Nitrous Oxide. Letters to Health Professionals Assistance to the Birth Partners Physician Leadership: Essential in Creating a Culture of Safety COVID-19 Airway Management: Better Care through Simulation • LITFL. Life in the Fast Lane • LITFL • Medical Blog